Anti-CHD9 antibodies are used in the immunodetection of the protein chromodomain helicase DNA binding protein 9. In humans, the canonical protein has a reported length of 2897 amino acid residues and a mass of 326 kDa. Its subcellular localization is in the nucleus and cytoplasm. Up to 3 different isoforms have been reported for this protein. It is found to be widely expressed at low levels. A member of the SNF2/RAD54 helicase protein family, CHD9 is known to act as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Synonyms for this target antigen include PPAR-alpha-interacting complex protein 320 kDa, PPAR{gamma}-interacting cofactor 320 kDa, chromatin remodeling factor CHROM1, chromatin-related mesenchymal modulator, and ATP-dependent helicase CHD9. CHD9 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of CHD9 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.